Phosphorylation of cyclin dependent kinase 4 on tyrosine 17 is mediated by Src family kinases

Nicholas G Martin1, Peter C McAndrew, Paul D Eve

  • 1Centre for Cancer Therapeutics at The Institute of Cancer Research, Cancer Research UK, Haddow Laboratories, 15 Cotswold Road, Sutton, Surrey, UK.

The FEBS Journal
|May 16, 2008
PubMed

Insights

Src family kinases, not WEE1 or MYT1, phosphorylate cyclin-dependent kinase 4 at tyrosine 17. This finding clarifies regulation of cyclin-dependent kinase 4 (CDK4) activity, a key cell cycle regulator often altered in cancer.

Area of Science:

  • Molecular Biology
  • Cell Cycle Regulation
  • Cancer Biology

Background:

  • Cyclin-dependent kinase 4 (CDK4) is a critical regulator of the cell cycle.
  • Deregulation of CDK4 activity is common in various cancers.
  • The phosphorylation of CDK4 at tyrosine 17 (pY17) is a known regulatory mechanism, but the responsible kinases were unidentified.

Purpose of the Study:

  • To identify the kinases responsible for phosphorylating cyclin-dependent kinase 4 (CDK4) at tyrosine 17.
  • To elucidate the regulatory mechanisms controlling CDK4 activity through pY17 phosphorylation.

Main Methods:

  • Generation of a phosphospecific antibody for pY17-CDK4.
  • Purification of tyrosine 17 kinases from HeLa cell lysates.
  • In vitro kinase assays and cell transfection experiments.
  • Treatment with Src family kinase inhibitors.

Main Results:

  • Tyrosine 17 of CDK4 is phosphorylated at low levels in proliferating HCT116 cells.
  • The Src family kinase C-YES was identified as a major contributor to pY17-CDK4 activity in HeLa cells.
  • C-YES directly phosphorylated CDK4 at Y17 in transfected cells.
  • Inhibition of Src family kinases reduced pY17-CDK4 levels in cells.

Conclusions:

  • Src family kinases, including C-YES, are the primary kinases phosphorylating CDK4 at tyrosine 17.
  • WEE1 and MYT1 do not phosphorylate CDK4 at this site.
  • This study clarifies the regulation of CDK4 activity via Y17 phosphorylation, offering insights into cancer-related signaling pathways.

Related Concept Videos

Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...